共 15 条
[1]
High levels of IL10 secreting cells are present in blood in cerebrovascular diseases. Pelidou SH,Kostulas N,Matusevicius D,et al. European Journal of Neurology . 1999
[2]
The selected pro-and anti -inflammatory cytokines in the patients with coronary heart disease: preliminary communication. Mizia-Stec K,Zahorska-Markiewicz B,Mandecki T,et al. Polskie Archiwum Medycyny Wewnetrznej . 1999
[3]
Interleukin-10 Inhibits intimal hyperlasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Feldman LJ,Aguirre L,Ziol M,et al. Circulation . 2000
[4]
Effects of physical therapy on cytokines and two color analysis-lymphocyte subsets in patients with cerebrovascular diseases. Kurabayashi H,Machida I,Handa H,et al. Journal of Medicine . 1999
[5]
Invitro effects of interleukin-10, prednisolone, and GM CSF on the nonspecific immune function of human polymorphonuclear leucocytes and monocytes. Ziege SU,Geerdes Fenge HF,Rau M,et al. European Journal of Medical Research . 2000
[6]
Expression of interleukin-10in advanced human atherosclerotic plaques:relationtoinducible nitric oxide synthase expression and cell death. Mallat Z,Heymes C,Ohan J,et al. Arteriosclerosis and Thrombosis . 1999
[7]
Immunosuppressive and anti-inflammatory properties of interleukin 10. de Vries JE. Annals of Medicine . 1995
[8]
Interleukin-10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. de Waal Malefyt R,Abrams RJ,Bennett B,et al. The Journal of Experimental Medicine . 1991
[9]
High levels of interleukin-10 in serum are associated with fatality in meningococcal disease. Lehmann AK,Halstensen A,Sornes S,et al. Infection and Immunity . 1995
[10]
Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. Mallat Z,Ohan J,Leseche G,et al. Circulation . 1997